Literature DB >> 9622062

Germ-line deletion involving the INK4 locus in familial proneness to melanoma and nervous system tumors.

M Bahuau1, D Vidaud, R B Jenkins, I Bièche, D W Kimmel, B Assouline, J S Smith, B Alderete, J M Cayuela, J P Harpey, B Caille, M Vidaud.   

Abstract

Joint predisposition to malignant melanoma and nervous system tumors (NSTs) is a puzzle. Several melanoma susceptibility genes have been identified, including p16, a clustered tumor suppressor. However, the molecular bases of inherited proclivity to NSTs in the absence of a recognizable genetic syndrome are unknown. We analyzed two families with joint proneness to melanoma and NSTs in view of genetic linkage and identification of the causal molecular lesions. Highly informative linkage markers were used for segregation analyses of the predisposition alleles in the two pedigrees. Characterization of the molecular lesions required hemizygosity mapping based on microsatellite markers physically mapped to contigs of the 9p21 region and a Southern blot approach using several PCR-generated probes. Both families were found to be allelic and linked to p16 markers. In the family segregating the melanoma/NST syndrome, a large germ-line deletion ablated the whole p16, p19, and p15 gene cluster (or INK4 locus), whereas a more circumscribed molecular lesion disrupting p16 and p19 but leaving p15 unaltered segregated with the melanoma-astrocytoma syndrome (MIM 155755). Our results suggest that multiple cancer susceptibility in these two families ensues from contiguous tumor suppressor gene deletion. Indeed, known phenotypes associated with germ-line p16 mutations and an apparent correlation between the deletion span and tumor spectrum in the two families suggest a new model of cancer pathogenesis based on the inactivation of contiguous tumor suppressor genes, an alternative to the established pleiotropic effects of single-gene disruption.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9622062

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  48 in total

1.  Survey of familial glioma and role of germline p16INK4A/p14ARF and p53 mutation.

Authors:  Lindsay B Robertson; Georgina N Armstrong; Bianca D Olver; Amy L Lloyd; Sanjay Shete; Ching Lau; Elizabeth B Claus; Jill Barnholtz-Sloan; Rose Lai; Dora Il'yasova; Joellen Schildkraut; Jonine L Bernstein; Sara H Olson; Robert B Jenkins; Ping Yang; Amanda Lynn Rynearson; Amanda L Rynerason; Margaret Wrensch; Lucie McCoy; John K Wienkce; Bridget McCarthy; Faith Davis; Nicholas A Vick; Christoffer Johansen; Hanne Bødtcher; Siegal Sadetzki; Revital Bar-Sade Bruchim; Galit Hirsh Yechezkel; Ulrika Andersson; Beatrice S Melin; Melissa L Bondy; Richard S Houlston
Journal:  Fam Cancer       Date:  2010-09       Impact factor: 2.375

2.  The CDKN2A-CDKN2B rs4977756 polymorphism and glioma risk: a meta-analysis.

Authors:  Hongwei Lu; Yuantao Yang; Jihui Wang; Yang Liu; Ming Huang; Xinlin Sun; Yiquan Ke
Journal:  Int J Clin Exp Med       Date:  2015-10-15

3.  Conditional expression of the tumor suppressor p16 in a heterotopic glioblastoma model results in loss of pRB expression.

Authors:  Matthias Simon; Christian Simon; Gertraud Köster; Volkmar H J Hans; Johannes Schramm
Journal:  J Neurooncol       Date:  2002-10       Impact factor: 4.130

4.  Human keratinocytes that express hTERT and also bypass a p16(INK4a)-enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics.

Authors:  M A Dickson; W C Hahn; Y Ino; V Ronfard; J Y Wu; R A Weinberg; D N Louis; F P Li; J G Rheinwald
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

Review 5.  Genome-wide association studies of pigmentation and skin cancer: a review and meta-analysis.

Authors:  Meg R Gerstenblith; Jianxin Shi; Maria Teresa Landi
Journal:  Pigment Cell Melanoma Res       Date:  2010-07-16       Impact factor: 4.693

6.  Associations of high-grade glioma with glioma risk alleles and histories of allergy and smoking.

Authors:  Daniel H Lachance; Ping Yang; Derek R Johnson; Paul A Decker; Thomas M Kollmeyer; Lucie S McCoy; Terri Rice; Yuanyuan Xiao; Francis Ali-Osman; Frances Wang; Shawn M Stoddard; Debra J Sprau; Matthew L Kosel; John K Wiencke; Joseph L Wiemels; Joseph S Patoka; Faith Davis; Bridget McCarthy; Amanda L Rynearson; Joel B Worra; Brooke L Fridley; Brian Patrick O'Neill; Jan C Buckner; Dora Il'yasova; Robert B Jenkins; Margaret R Wrensch
Journal:  Am J Epidemiol       Date:  2011-07-08       Impact factor: 4.897

Review 7.  Germline mutations predisposing to melanoma.

Authors:  Atrin Toussi; Nicole Mans; Jeanna Welborn; Maija Kiuru
Journal:  J Cutan Pathol       Date:  2020-05-11       Impact factor: 1.587

8.  Genome-wide association study identifies five susceptibility loci for glioma.

Authors:  Sanjay Shete; Fay J Hosking; Lindsay B Robertson; Sara E Dobbins; Marc Sanson; Beatrice Malmer; Matthias Simon; Yannick Marie; Blandine Boisselier; Jean-Yves Delattre; Khe Hoang-Xuan; Soufiane El Hallani; Ahmed Idbaih; Diana Zelenika; Ulrika Andersson; Roger Henriksson; A Tommy Bergenheim; Maria Feychting; Stefan Lönn; Anders Ahlbom; Johannes Schramm; Michael Linnebank; Kari Hemminki; Rajiv Kumar; Sarah J Hepworth; Amy Price; Georgina Armstrong; Yanhong Liu; Xiangjun Gu; Robert Yu; Ching Lau; Minouk Schoemaker; Kenneth Muir; Anthony Swerdlow; Mark Lathrop; Melissa Bondy; Richard S Houlston
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

9.  Some molecular and clinical aspects of genetic predisposition to malignant melanoma and tumours of various site of origin.

Authors:  Tadeusz Debniak
Journal:  Hered Cancer Clin Pract       Date:  2007-06-15       Impact factor: 2.857

10.  Variants in the CDKN2B and RTEL1 regions are associated with high-grade glioma susceptibility.

Authors:  Margaret Wrensch; Robert B Jenkins; Jeffrey S Chang; Ru-Fang Yeh; Yuanyuan Xiao; Paul A Decker; Karla V Ballman; Mitchel Berger; Jan C Buckner; Susan Chang; Caterina Giannini; Chandralekha Halder; Thomas M Kollmeyer; Matthew L Kosel; Daniel H LaChance; Lucie McCoy; Brian P O'Neill; Joe Patoka; Alexander R Pico; Michael Prados; Charles Quesenberry; Terri Rice; Amanda L Rynearson; Ivan Smirnov; Tarik Tihan; Joe Wiemels; Ping Yang; John K Wiencke
Journal:  Nat Genet       Date:  2009-07-05       Impact factor: 38.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.